Strong Portfolio

Sandoz develops, produces and markets medicines that are no longer protected by patents, along with pharmaceutical and biotechnological active substances. This gives us a broad range of products, within which the cardiovascular system and anti-infectives are particular areas of focus.

Sandoz offers more than 950 generic compounds in over 5 000 forms worldwide. It develops and manufactures off-patent medicines into finished dosage forms and sells them to wholesalers, pharmacies, hospitals and other healthcare outlets. Separate business units focus on anti-infectives and biopharmaceuticals respectively.

Sandoz differentiates itself by its ability to develop and produce difficult-to-make generics. The broad portfolio ranges from advanced application forms such as oral solids, through complex technologies such as inhalers or injectables to transdermal patches, implants and biopharmaceutical follow-ons (biosimilars).